Archiwa NanoSanguis - Page 2 of 5 - Nanotechnologia w medycynie

NanoSanguis Scientific Council: profile of prof. Tomasz Ciach

An expert in the field of nanotechnology, researcher, inventor, author of two technologies, dozens of patents and over 50 publications – this is a bri…

NanoGroup strengthens its team: leading transplant and life science experts support innovative NanOX project

Prof. Ph. Eng. Tomasz Ciach has become the head of the Scientific Council established at NanoSanguis S.A. The newly established team will include lead…

eCapital increases involvement in NanoGroup S.A.

Michal Lach, through the company he owns company eCapital, increasedhe increased its capital commitment to NanoGroup SA. The investor subscribed to&nb…

NanOX system tested during experimental kidney autotransplantation procedure

This was probably one of the most complex and technologically advanced procedures currently being performed in our country in preclinical and clinical…

Michal Lach and Robert Dziublowski increase their involvement in NanoGroup S.A.

On July 10, 2024, the company announced that two of its main investors: Michał Lach and Robert Dziubłowski significantly increased their involvement in&nbs…

CET’s acquisition of NanoSanguis S.A. shares.

In December 2023, we informed about concluding an advisory agreement with CET Advisors LTD in the commercialization process of projects conducted…